Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$61,628,269
+$34,632,306 QoQ
Shares Held
67,004
+166.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$27,593,100
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $179,007,948 across 10 Drug Manufacturers - General names. LLY ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
67,004 | $61,628,269 | |
| 2 | JNJ |
Johnson & Johnson
|
164,590 | $40,232,379 | |
| 3 | BIIB |
Biogen Inc.
|
201,367 | $36,916,612 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
100,010 | $13,938,393 | |
| 5 | MRK |
Merck & Co., Inc.
|
101,505 | $12,210,036 | |
| 6 | NVO |
Novo Nordisk A S
|
125,038 | $4,595,146 | |
| 7 | ABBV |
AbbVie Inc.
|
20,010 | $4,351,974 | |
| 8 | PFE |
Pfizer Inc
|
90,000 | $2,527,200 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,593,100 | 30,000 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $61,628,269 | 67,004 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $26,995,963 | 25,120 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $42,987,204 | 40,000 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $33,965,708 | 44,516 | Shares | Sole | 2025-12-15 | |
| 2025-09-30 | $72,485,000 | 95,000 | Call | Sole | 2025-12-15 | |
| 2025-09-30 | $91,560,000 | 120,000 | Put | Sole | 2025-12-15 | |
| 2025-06-30 | $175,316,297 | 224,900 | Put | Sole | 2025-08-18 | |
| 2025-06-30 | $191,945,230 | 246,232 | Shares | Sole | 2025-08-18 | |
| 2025-06-30 | $2,182,684 | 2,800 | Call | Sole | 2025-08-18 | |
| 2025-03-31 | $322,999,360 | 391,083 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $167,742,321 | 203,100 | Put | Sole | 2025-05-14 | |
| 2024-12-31 | $206,455,188 | 267,429 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $247,040,000 | 320,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $30,880,000 | 40,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $70,875,200 | 80,000 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $70,875,200 | 80,000 | Put | Sole | 2024-11-13 | |
| 2024-06-30 | $353,098,200 | 390,000 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $353,098,200 | 390,000 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $15,559,200 | 20,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $16,064,692 | 27,559 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,742,600 | 20,000 | Shares | Sole | 2023-12-07 | |
| 2023-06-30 | $11,958,990 | 25,500 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $73,168,000 | 200,000 | Shares | Sole | 2023-02-14 | |
| 2021-03-31 | $934,100 | 5,000 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||